Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    kns
Show Display Options
Rank Status Study
1 Completed Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: KNS-760704
2 Completed Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: KNS-760704;   Drug: Placebo
3 Recruiting Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Interventions: Drug: Dexpramipexole;   Drug: Corticosteroid Taper
4 Recruiting Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia
Condition: Chronic Sinusitis With Nasal Polyps and Eosinophilia
Intervention: Drug: dexpramipexole
5 Active, not recruiting
Has Results
Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)
Condition: Hepatitis B
Interventions: Drug: Tenofovir disoproxil fumarate (TDF) tablets;   Drug: Adefovir dipivoxil (ADV) tablets
6 Recruiting Vandetanib in Advanced NSCLC With RET Rearrangement
Condition: Non Small Cell Lung Cancer
Intervention: Drug: Vandetanib

Indicates status has not been verified in more than two years